O	0	9	Antisense	Antisense	JJ	B-NP
O	10	22	technologies	technology	NNS	I-NP
O	23	27	have	have	VBP	B-VP
O	28	29	a	a	DT	B-NP
O	30	36	future	future	JJ	I-NP
O	37	45	fighting	fighting	NN	I-NP
O	46	63	neurodegenerative	neurodegenerative	JJ	I-NP
O	64	72	diseases	disease	NNS	I-NP
O	72	73	.	.	.	O

O	74	77	Our	Our	PRP$	B-NP
O	78	85	growing	grow	VBG	I-NP
O	86	99	understanding	understanding	NN	I-NP
O	100	102	of	of	IN	B-PP
O	103	106	the	the	DT	B-NP
O	107	111	role	role	NN	I-NP
O	112	116	that	that	WDT	B-NP
O	117	128	unfavorable	unfavorable	JJ	B-NP
O	129	137	patterns	pattern	NNS	I-NP
O	138	140	of	of	IN	B-PP
O	141	145	gene	gene	NN	B-NP
O	146	156	expression	expression	NN	I-NP
O	157	161	play	play	NN	I-NP
O	162	164	in	in	IN	B-PP
O	165	168	the	the	DT	B-NP
O	169	177	etiology	etiology	NN	I-NP
O	178	180	of	of	IN	B-PP
O	181	198	neurodegenerative	neurodegenerative	JJ	B-NP
O	199	206	disease	disease	NN	I-NP
O	207	217	emphasizes	emphasize	VBZ	B-VP
O	218	221	the	the	DT	B-NP
O	222	226	need	need	NN	I-NP
O	227	230	for	for	IN	B-SBAR
O	231	241	strategies	strategy	NNS	B-NP
O	242	244	to	to	TO	B-VP
O	245	256	selectively	selectively	RB	I-VP
O	257	262	block	block	VB	I-VP
O	263	266	the	the	DT	B-NP
O	267	279	biosynthesis	biosynthesis	NN	I-NP
O	280	282	of	of	IN	B-PP
O	283	290	harmful	harmful	JJ	B-NP
O	291	299	proteins	protein	NNS	I-NP
O	300	302	in	in	IN	B-PP
O	303	306	the	the	DT	B-NP
B-Organ	307	312	brain	brain	NN	I-NP
O	312	313	.	.	.	O

O	314	323	Antisense	Antisense	JJ	B-NP
O	324	336	technologies	technology	NNS	I-NP
O	337	340	are	be	VBP	B-VP
O	341	348	ideally	ideally	RB	I-VP
O	349	355	suited	suit	VBN	I-VP
O	356	358	to	to	TO	B-PP
O	359	363	this	this	DT	B-NP
O	364	371	purpose	purpose	NN	I-NP
O	371	372	.	.	.	O

O	373	379	Tailor	Tailor	NN	B-NP
O	379	380	-	-	HYPH	B-VP
O	380	388	designed	design	VBN	I-VP
O	389	391	to	to	TO	I-VP
O	392	398	target	target	VB	I-VP
O	399	407	specific	specific	JJ	B-NP
O	408	411	RNA	RNA	NN	I-NP
O	411	412	,	,	,	O
O	413	422	antisense	antisense	JJ	B-NP
O	423	439	oligonucleotides	oligonucleotide	NNS	I-NP
O	440	443	and	and	CC	I-NP
O	444	453	ribozymes	ribozyme	NNS	I-NP
O	454	459	offer	offer	VBP	B-VP
O	460	465	tools	tool	NNS	B-NP
O	466	468	to	to	TO	B-VP
O	469	477	suppress	suppress	VB	I-VP
O	478	481	the	the	DT	B-NP
O	482	492	production	production	NN	I-NP
O	493	495	of	of	IN	B-PP
O	496	504	proteins	protein	NNS	B-NP
O	505	514	mediating	mediate	VBG	B-VP
O	515	532	neurodegeneration	neurodegeneration	NN	B-NP
O	532	533	.	.	.	O

O	534	542	Although	Although	IN	B-SBAR
O	543	552	technical	technical	JJ	B-NP
O	553	564	limitations	limitation	NNS	I-NP
O	565	569	must	must	MD	B-VP
O	570	575	still	still	RB	I-VP
O	576	578	be	be	VB	I-VP
O	579	587	overcome	overcome	VBN	I-VP
O	587	588	,	,	,	O
O	589	592	the	the	DT	B-NP
O	593	602	antisense	antisense	JJ	I-NP
O	603	611	approach	approach	NN	I-NP
O	612	622	represents	represent	VBZ	B-VP
O	623	624	a	a	DT	B-NP
O	625	630	novel	novel	JJ	I-NP
O	631	634	and	and	CC	I-NP
O	635	643	exciting	exciting	JJ	I-NP
O	644	652	strategy	strategy	NN	I-NP
O	653	656	for	for	IN	B-PP
O	657	669	intervention	intervention	NN	B-NP
O	670	672	in	in	IN	B-PP
O	673	681	diseases	disease	NNS	B-NP
O	682	684	of	of	IN	B-PP
O	685	688	the	the	DT	B-NP
B-Anatomical_system	689	696	central	central	JJ	I-NP
I-Anatomical_system	697	704	nervous	nervous	JJ	I-NP
I-Anatomical_system	705	711	system	system	NN	I-NP
O	711	712	.	.	.	O

